US Broker Ratings

Boston Scientific Corporation (BSX) Stock Analysis: 44% Potential Upside Signals Promising Investment Opportunity

For investors eyeing opportunities in the healthcare sector, Boston Scientific Corporation (NYSE: BSX) stands out with its robust market presence and promising potential upside. With a market capitalization of $85.88..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring Growth Potential Amid Robust Revenue Gains

Investors eyeing opportunities in the healthcare sector should pay close attention to Novo Nordisk A/S (NVO), a Danish pharmaceutical giant with a commanding presence in diabetes and obesity care. With..

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Giant’s 5.99% Upside Potential Captivates Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable name in the global healthcare sector, showcasing a robust market capitalization of $302.33 billion. As one of the prominent players..

Regeneron Pharmaceuticals, Inc. (REGN): Analyst Ratings Signal Strong Buy with 30% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a titan in the biotechnology industry, has been capturing the attention of investors with a promising 30.43% potential upside. With its current price at $638.88,..

ResMed Inc. (RMD) Stock Analysis: Robust Growth Potential Amidst Healthcare Innovations

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, has been making significant strides in the medical instruments and supplies industry. With a market capitalization of $30.18 billion, ResMed..

McKesson Corporation (MCK) Stock Analysis: Exploring a 23.97% Potential Upside and Solid Growth Prospects

Investors looking to diversify their portfolios with a robust player in the healthcare sector might find McKesson Corporation (NYSE: MCK) a compelling choice. With a commanding market capitalization of $92.09..

Novartis AG (NVS) Stock Analysis: Strong ROE and Strategic Focus Positioning for Growth

Novartis AG (NYSE: NVS), a leading player in the healthcare sector, specifically within the drug manufacturing industry, has once again caught the eye of investors with its robust financial metrics..

AbbVie Inc. (ABBV) Stock Analysis: Unraveling a 17% Potential Upside Amid Robust Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector specializing in drug manufacturing, has captured investor attention with a notable 17.24% potential upside. The biopharmaceutical giant, with a market..

Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside

Inspire Medical Systems, Inc. (NYSE: INSP) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. Headquartered in Golden Valley, Minnesota, Inspire Medical has carved out..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is attracting attention from investors with its focus on developing innovative treatments for severe endocrinologic, oncologic, metabolic, and neurologic disorders. With a market capitalization of..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 103% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, is gaining attention for its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. With a market capitalization of..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Strong Buy with 10.83% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a notable player within the healthcare sector, specifically in the niche of specialty and generic drug manufacturing. With a market capitalization of $6.11..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 6.19% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, operates in the specialized and generic drug manufacturing industry. With a market capitalization of $19.19 billion, Viatris has established..

Soleno Therapeutics, Inc. (SLNO) Stock Report: A Biotech Player with Steady ROE and Strategic Focus on Rare Diseases

Soleno Therapeutics, Inc. (NASDAQ: SLNO) stands out in the biotechnology sector with its strategic focus on treating rare diseases. With a market capitalization of $2.76 billion, this Redwood City-based company..

Bio-Techne Corp (TECH) Stock Analysis: Unlocking a 41.84% Upside Potential in Healthcare Innovation

Bio-Techne Corporation (NASDAQ: TECH), a pioneering entity in the biotechnology arena, offers investors a fascinating opportunity with a significant potential upside of 41.84%. As a key player in the healthcare..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 19.93% Potential Upside in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a titan in the medical distribution sector, stands as a compelling choice for investors looking to tap into the healthcare industry. With a market capitalization..

Cytokinetics, Incorporated (CYTK): Investor Outlook with a 38% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, capturing investor attention with its innovative approach to treating muscle-related diseases. Headquartered in South San Francisco, California, this..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and Promising 5.38% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS), a Pittsburgh-based player in the biotechnology sector, is making significant waves in the healthcare industry with its genetic medicines targeting diseases with high unmet needs...

West Pharmaceutical Services (WST) Stock Analysis: Strong Growth Potential with a 15.5% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the healthcare sector, commands significant attention from investors due to its robust market presence and promising growth trajectory. This Exton,..

BrightSpring Health Services (BTSG) Stock Analysis: Strong Buy Ratings and Promising Growth in Healthcare

BrightSpring Health Services, Inc. (BTSG) is emerging as a compelling investment opportunity in the Health Information Services industry, driven by robust buy ratings and impressive revenue growth. Headquartered in Louisville,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds